Compound Detail

CHEMBL4646810

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

C=C1C(=O)O[C@H]2[C@H]1CCC(/C=N/NC(=O)NCCCC)=C\CC[C@@]1(C)O[C@@H]21

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4646810
Phase	Preclinical
Structure Type	MOL
InChI Key	SIARFVBTBUCVJS-ZDBMLTPASA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

375.5

MW (Da)

2.83

ALogP

HBA

HBD

92.3

PSA (Å²)

0.19

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 5 meas. best 5.57

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HCT-116 CHEMBL394	IC50	5.57	5.57	2720.0	1
U-87 MG CHEMBL614247	IC50	5.32	5.32	4770.0	1
HepG2 CHEMBL395	IC50	5.23	5.23	5880.0	1
PC-9 CHEMBL614102	IC50	5.06	5.06	8670.0	1
BGC-823 CHEMBL614526	IC50	4.84	4.84	14400.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HCT-116	IC50	=	2720.0	nM	5.57	Antiproliferation activity against human HCT116 cells assessed as reduction in c...	32546298
U-87 MG	IC50	=	4770.0	nM	5.32	Antiproliferation activity against human U87MG cells assessed as reduction in ce...	32546298
HepG2	IC50	=	5880.0	nM	5.23	Antiproliferation activity against human HepG2 cells assessed as reduction in ce...	32546298
PC-9	IC50	=	8670.0	nM	5.06	Antiproliferation activity against human PC9 cells assessed as reduction in cell...	32546298
BGC-823	IC50	=	14400.0	nM	4.84	Antiproliferation activity against human BGC823 cells assessed as reduction in c...	32546298

PubMed	DOI	Target Context	# Activities
32546298	10.1016/j.bmc.2020.115557	U-87 MG	1
32546298	10.1016/j.bmc.2020.115557	HCT-116	1
32546298	10.1016/j.bmc.2020.115557	HepG2	1
32546298	10.1016/j.bmc.2020.115557	BGC-823	1
32546298	10.1016/j.bmc.2020.115557	PC-9	1

Data from ChEMBL 36 via Core Engine